FMB
TEVA icon

Field & Main Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Field & Main Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$971K Sell
16,425
-3,375
-17% -$208K 0.92% 43
2015
Q1 		$1.23M Sell
19,800
-250
-1% -$14.5K 1.14% 31
2014
Q4 		$1.15M Sell
20,050
-2,700
-12% -$150K 1.08% 36
2014
Q3 		$1.22M Hold
22,750
– – 1.15% 31
2014
Q2 		$1.19M Sell
22,750
-350
-2% -$17.9K 1.11% 34
2014
Q1 		$1.22M Buy
23,100
+1,400
+6% +$64.7K 1.18% 29
2013
Q4 		$870K Buy
+21,700
New +$854K 0.85% 49

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Field & Main Bank's TEVA Position: Q2 2015 in Review

Field & Main Bank reduced its Teva Pharmaceuticals (TEVA) stake by 17% in Q2 2015, selling an estimated $208K and leaving 16,425 shares worth $971K. The position accounts for 0.92% of the portfolio, ranked #43.

Field & Main Bank first reported a position in TEVA in Q4 2013 and has held it in 7 quarters since. The position peaked at $1.23M in Q1 2015. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Field & Main Bank held 16,425 shares of Teva Pharmaceuticals worth $971K as of Q2 2015.
  • Field & Main Bank sold 3,375 Teva Pharmaceuticals shares in Q2 2015, an estimated $208K.
  • Teva Pharmaceuticals made up 0.92% of Field & Main Bank's portfolio in Q2 2015, its #43 holding.
  • Field & Main Bank first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 7 quarters since.
  • Field & Main Bank's Teva Pharmaceuticals position peaked at $1.23M in Q1 2015.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Field & Main Bank's 13F filing for Q2 2015, filed 22 Jul 2015.